Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127314171 | 12731417 | 1 | I | 20160901 | 20160912 | 20160912 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-074442 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160912 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127314171 | 12731417 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 0.5 ML, QD | 4L78655A | 21713 | .5 | ML | ORAL SOLUTION | QD | |||||
| 127314171 | 12731417 | 2 | C | XANAX | ALPRAZOLAM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127314171 | 12731417 | 1 | Agitation |
| 127314171 | 12731417 | 2 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127314171 | 12731417 | Circumstance or information capable of leading to medication error | |
| 127314171 | 12731417 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |